Browsing by Subject "trivalent inactivated split"
Now showing items 1-3 of 3
-
Safety and immunogenicity of a seasonal trivalent inactivated split influenza vaccine: a phase I randomized clinical trial in healthy Serbian adults
(Taylor & Francis Inc, Philadelphia, 2018)